---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-038139"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2024-09-25T23:59:59+00:00"
generated_at: "2026-05-31T01:45:54.066963+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix enters new employment agreements with CEO and CFO through Aug 2025

## Summary
- CEO Brian Murphy new agreement: $321K base salary, up to $100K annual bonus, effective Sept 20, 2024 to Aug 31, 2025.
- CFO Stephen Brown new agreement: $267.5K base salary, up to $50K annual bonus, same term as CEO.
- Both agreements allow termination on 90 days notice; severance of 12 months base plus ancillary payments if terminated without cause or for good reason.
- CEO and CFO eligible for future stock option grants under a new equity incentive plan to be adopted.
- Existing 2022 employment agreements were terminated upon effectiveness of new agreements.

## SEC filing metadata
- accession: 0001493152-24-038139
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2024-09-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315224038139/0001493152-24-038139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315224038139/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-038139
- JSON: https://secwatch.observer/filing/0001493152-24-038139.json
- Plain text: https://secwatch.observer/filing/0001493152-24-038139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.